Research Archives

Why Clinical Trials Fail: FSR’s New Initiative to Bridge Gap between Industry Leaders, Researchers, and Patients

Aug 5, 2016

Guest post written by Sue Bhalla As the latest industry statistics show, an estimated 90% of drugs that reach the testing phase of clinical trials never end up marking the finish line and attaining FDA approval. This leaves potentially useful drug therapies far from...

Topics: News/ Research

Accelerate Research for Sarcoidosis at K.I.S.S. 5K in Chicago!

Mar 16, 2016

Kick In to Stop Sarcoidosis at the Foundation for Sarcoidosis Research’s 3rd Annual 5K in Chicago, IL! Saturday, April 30, 2016 at 10:30am Grove 3, Lincoln Park, Chicago, IL You will help us create a movement by raising awareness for sarcoidosis and doing your...

Topics: Research/ Team KISS

SAKURA Phase III Study

Nov 13, 2015

The SAKURA study is a Phase III, multinational, double-masked trial investigating the safety and efficacy of DE-109 for the treatment of non-infectious uveitis of the posterior segment. DE-109 is a proprietary formulation of sirolimus that is an anti-inflammatory...

Topics: Research

Excessive daytime sleepiness and obstructive sleep apnea in patients with sarcoidosis

Dec 1, 2012

Patterson KC, Huang F, Oldham J, Bhardwaj N, Hogarth DK, Mokhlesi B. Abstract ABSTRACT BACKGROUND: Systemic symptoms are common in sarcoidosis and are associated with a decreased quality of life. Excessive daytime sleepiness (EDS) is often associated with obstructive...

Topics: Research

Category: Research

Why Clinical Trials Fail: FSR’s New Initiative to Bridge Gap between Industry Leaders, Researchers, and Patients

Accelerate Research for Sarcoidosis at K.I.S.S. 5K in Chicago!

SAKURA Phase III Study

Excessive daytime sleepiness and obstructive sleep apnea in patients with sarcoidosis

Categories

Recent Posts